Institut Claudius-Regaud (ICR) UNICANCER
Research facility
Location:
Toulouse,
France (FR)
ISNI: 0000000096800846
ROR: https://ror.org/03pa87f90
Show on Map:
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) (2020)
Terpos E, Engelhardt M, Cook G, Gay F, Mateos MV, Ntanasis-Stathopoulos I, Van De Donk NWCJ, et al.
Journal article, Review article
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma (2019)
Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, et al.
Journal article
European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: What to use and when (2018)
Caers J, Garderet L, Kortuem KM, O'Dwyer ME, Van De Donk NWCJ, Binder M, Dold SM, et al.
Journal article
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+ (2015)
Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, Bex A, et al.
Journal article